Gut extracellular vesicles promote alcohol-induced liver injury via TLR4-regulated miRNAs
肠道细胞外囊泡通过 TLR4 调节的 miRNA 促进酒精引起的肝损伤
基本信息
- 批准号:9753076
- 负责人:
- 金额:$ 18.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAlcoholic Liver DiseasesAlcoholsAntigensAttenuatedAutomobile DrivingCell physiologyCellsChronicColitisColon CarcinomaDataDevelopmentDietDistantEpithelialEpithelial CellsEventFoundationsFutureGoalsHepaticHepatocyteHypoxiaImmuneImmune signalingImmunotherapyImpairmentIn VitroInflammationInflammatoryInflammatory disease of the intestineInjuryInterventionIntestinal permeabilityIntestinesInvestigationKupffer CellsLeadLinkLiverLiver diseasesMacrophage ActivationMediatingMicroRNAsMolecularMyeloid CellsOutcomePathogenicityPatientsPlayPreventiveProductionProteinsPublishingRegulationRoleSeveritiesSignal TransductionTLR4 geneTestingTherapeuticTumor AngiogenesisUlcerative ColitisWorkantimicrobialbasechronic alcohol ingestionexosomeextracellularextracellular vesiclesgut microbiotagut-liver axisimmunoregulationimprovedin vivoinhibitor/antagonistinterestliver developmentliver inflammationliver injurymacrophagemicrobialmicroorganism antigenmigrationmouse modelnanoparticlenanovesiclenovelnutritionoverexpressionpreventrecruitresponsetherapeutic targettranslational studyvesicular release
项目摘要
The overarching theme of this project is to explore the mechanisms that lead to immune regulation of alcoholic
liver disease (ALD). We will focus on extracellular vesicles (EVs) of gut and hepatic macrophages. Specifically,
we will examine how microbial antigen stimulates the production of gut EVs through TLR4 signaling and the
consequences of these events in the development of ALD via gut-liver axis. Novel in vitro and in vivo approaches
will be used to address mechanisms of action with the goal of identifying new targets for intervention. We
propose that gut-derived EVs regulate the accumulation and polarization of hepatic macrophages during
alcohol-induced chronic inflammation via TLR4 signaling. We specifically propose that TLR4-activated
extracelluar miRNAs production is the key to the activation of macrophages. Based on our published work
and other preliminary data, this proposal will test the hypothesis that microbial antigen regulates the production
of gut extracellular miRNAs through TLR4 signaling, which initiates a crosstalk among macrophages and
hepatocytes in ALD. Moreover, we will determine whether diet-associated nanoparticles carrying inflammatory
miRNAs inhibitor have potential therapeutic implications in ALD. These hypotheses will be tested in the following
Specific Aims: Aim 1: Determine the role of TLR4-regulated gut EVs on alcohol-induced liver inflammation
and injury. Aim 2: Determine whether alteration of IEC miRNAs via TLR4 modulation affects the severity
of alcohol-induced liver inflammation and injury in ALD. Following the successful completion of the above
Specific Aims, our novel studies will (i) validate TLR4 activated EVs is directly relevant to the activation of hepatic
macrophages in ALD, (ii) define the preventive potential of TLR4-extracellular miRNAs axis in a mouse model of
ALD and (iii) provide a foundation for future mechanistic investigation of gut EVs and extracellular miRNA in ALD
therapy.
该项目的总体主题是探索导致酒精饮料免疫调节的机制
肝病(ALD)。我们将专注于肠道和肝巨噬细胞的细胞外囊泡(EV)。具体来说,
我们将研究微生物抗原如何通过TLR4信号传导刺激肠道电动汽车的产生
这些事件在通过肠叶轴发展中的后果。新颖的体外和体内方法
将用于解决行动机制,目的是确定新目标进行干预。我们
提出肠道衍生的电动汽车调节肝巨噬细胞的积累和极化
酒精引起的慢性炎症通过TLR4信号传导。我们明确提出了TLR4激活
外部miRNA的产生是巨噬细胞激活的关键。根据我们发表的工作
和其他初步数据,该提案将检验微生物抗原调节生产的假设
通过TLR4信号传导肠道外miRNA的肠外miRNA,这引发了巨噬细胞之间的串扰
Ald中的肝细胞。此外,我们将确定是否携带炎症的饮食相关纳米颗粒
miRNA抑制剂在ALD中具有潜在的治疗意义。这些假设将在以下测试
具体目的:目标1:确定TLR4调节的肠道电动汽车在酒精引起的肝脏炎症上的作用
和受伤。目标2:确定通过TLR4调制的IEC miRNA的改变是否会影响严重性
酒精引起的肝脏炎症和ALD损伤。成功完成以上
具体目的,我们的新研究将(i)验证TLR4激活的EV与肝的激活直接相关
ALD中的巨噬细胞,(ii)定义了在小鼠模型中TLR4-纤维细胞miRNA轴的预防潜力
ALD和(iii)为对ALD中肠道电动汽车和细胞外miRNA的未来机械研究奠定了基础
治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhong-Bin Deng其他文献
Zhong-Bin Deng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhong-Bin Deng', 18)}}的其他基金
The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation
中性神经酰胺酶在肠道岩藻糖基化以及肝脏脂肪变性和炎症中的作用
- 批准号:
10632084 - 财政年份:2022
- 资助金额:
$ 18.29万 - 项目类别:
The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation
中性神经酰胺酶在肠道岩藻糖基化以及肝脏脂肪变性和炎症中的作用
- 批准号:
10517197 - 财政年份:2022
- 资助金额:
$ 18.29万 - 项目类别:
Defining the role of S1p and myeloid cells during enterotoxigenic B. fragilis infection
定义 S1p 和骨髓细胞在产肠毒素脆弱拟杆菌感染过程中的作用
- 批准号:
10493352 - 财政年份:2021
- 资助金额:
$ 18.29万 - 项目类别:
Defining the role of S1p and myeloid cells during enterotoxigenic B. fragilis infection
定义 S1p 和骨髓细胞在产肠毒素脆弱拟杆菌感染过程中的作用
- 批准号:
10369893 - 财政年份:2021
- 资助金额:
$ 18.29万 - 项目类别:
Gut extracellular vesicles promote alcohol-induced liver injury via TLR4-regulated miRNAs
肠道细胞外囊泡通过 TLR4 调节的 miRNA 促进酒精引起的肝损伤
- 批准号:
9804746 - 财政年份:2018
- 资助金额:
$ 18.29万 - 项目类别:
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
CSN8 调节富含 S1P 的细胞外囊泡通过肠肝轴调节 NAFLD
- 批准号:
9913998 - 财政年份:2018
- 资助金额:
$ 18.29万 - 项目类别:
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
CSN8 调节富含 S1P 的细胞外囊泡通过肠肝轴调节 NAFLD
- 批准号:
10392896 - 财政年份:2018
- 资助金额:
$ 18.29万 - 项目类别:
Intestinal epithelial cells-derived exosomal miRNAs regulate liver inflammation in obesity
肠上皮细胞来源的外泌体 miRNA 调节肥胖中的肝脏炎症
- 批准号:
9385034 - 财政年份:2017
- 资助金额:
$ 18.29万 - 项目类别:
High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis
高脂饮食诱导肝细胞外泌体促进肝脏炎症和肿瘤发生
- 批准号:
8813882 - 财政年份:2016
- 资助金额:
$ 18.29万 - 项目类别:
High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis
高脂饮食诱导肝细胞外泌体促进肝脏炎症和肿瘤发生
- 批准号:
9293342 - 财政年份:
- 资助金额:
$ 18.29万 - 项目类别:
相似国自然基金
脂肪组织中SIRT3通过抑制外泌体miR-30a-3p调控肝脏自噬影响非酒精性脂肪肝病的机制研究
- 批准号:32360174
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
非酒精性脂肪性肝病对心肌梗死后修复和重构的影响:肝脏外泌体来源miRNA的关键作用
- 批准号:82270342
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
支链氨基酸及其代谢产物通过调控胆固醇代谢影响非酒精性脂肪性肝病的进展
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸及其代谢产物通过调控胆固醇代谢影响非酒精性脂肪性肝病的进展
- 批准号:32200965
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
BaP通过激活AhR调控FGF-21和雄激素受体影响非酒精性脂肪肝病的机制研究
- 批准号:82260733
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别:
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)
亚裔美国人预防研究:人口组学流行病学队列 (ARISE)
- 批准号:
10724884 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别:
Developing tools for calcium imaging in ITPR2-linked liver pathogenesis
开发 ITPR2 相关肝脏发病机制的钙成像工具
- 批准号:
10727998 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别:
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
- 批准号:
10646759 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别:
Establishing patient-derived iPSCs as a platform for discovery research in NAFLD
建立源自患者的 iPSC 作为 NAFLD 发现研究的平台
- 批准号:
10647450 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别: